Home Top Movers Companies Concepts

Market

Top Movers
Companies
Concepts

SEC Filings

AI Filing Analysis
Financial Reports
Current Reports
IPO Filings

Ownership

Institutional Holdings
Insider Trading

About

Data updates every 5 min
SEC EDGAR Source

© 2025–2026 StockGist|Information only, not investment advice

SCHEDULE 13G/A - Chemomab Therapeutics Ltd. | StockGist | StockGist

Companies
CMMB
SCHEDULE 13G/A

Home Top Movers Companies Concepts

Home Filings CMMBSCHEDULE 13G/A

SCHEDULE 13G/A

Beneficial Ownership

Amendment

Chemomab Therapeutics Ltd.

Filed Aug 11, 2025

Accepted Aug 10, 2025, 8:00 PM ET

CIK 0001534248

View on SEC.gov Company Profile

Beneficial Ownership Report

Passive Investment

Reporting Person

Chemomab Therapeutics Ltd.

Person Type

IN

CUSIP: 36322Q107

Amendment History

4 filings

SCHEDULE 13G
Original
Aug 7, 20250000895421-25-000481
SCHEDULE 13G/A
Amendment 1
Aug 7, 20250000895421-25-000497
SCHEDULE 13G/A
Amendment 2
Viewing
Aug 11, 20250001995601-25-000004
SCHEDULE 13G/A
Amendment 3
Latest
Feb 17, 20260001211060-26-000005

Recent Filings

Chemomab Therapeutics Ltd.1 weeks ago

Chemomab Therapeutics Ltd.2 weeks ago

Chemomab Therapeutics Ltd.1 months ago

Chemomab Therapeutics Ltd.1 months ago

Chemomab Therapeutics Ltd.4 months ago

Data Sources

Original SEC Filing SEC EDGAR Company Page

Market

Top Movers
Companies
Concepts

SEC Filings

AI Filing Analysis
Financial Reports
Current Reports
IPO Filings

Ownership

Institutional Holdings
Insider Trading

About

Data updates every 5 min
SEC EDGAR Source

© 2025–2026 StockGist|Information only, not investment advice